FOS and ovarian carcinoma: Based on these observations, we propose that β-elemene alters DNA repair activity and cisplatin sensitivity in human ovarian carcinoma cells by preventing the cisplatin-induced activation of PI3K/JNK and PI3K/Akt, consequently blocking the activation of the downstream transcription factors AP-1 and NF-κB.